RxDoctor Payments Data

Christopher McGreevy, MD

Surgical Oncology · Hackensack, NJNPI 1942599550

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Elucent Medical at 38.9% of the total. 2025 is the largest year on record at $805, 3.5 times the $232 reported in 2020. That places this record below the midpoint for surgical oncology clinicians in NJ, where the typical reported total is $1,132.

$1,238in general payments, 2019–2025

Across 18 payments — averaging $68.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Elucent Medical$481
  • Pacira Pharmaceuticals Incorporated$232
  • Davol Inc.$175
  • Merit Medical Systems Inc$151
  • Merck$44
  • Hologic Sales And Service, LLC$35
  • plus $121 from 5 others

What the payments were for

  • Food & beverage$1,238100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,238 in reported general payments places this provider in the 50th percentile of 59 surgical oncology providers in New Jersey.

See all surgical oncology providers in New Jersey

Medicare billing

Part B allowed, 2024
$81,170
Medicare patients
117
Services billed
366

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgical oncology in Hackensack

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →